Previously submitted to: JMIR Medical Informatics (no longer under consideration since Jun 23, 2021)
Date Submitted: Mar 31, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Research on Information Sensing for Measuring Endometrial Cancer by Magnetic Resonance Imaging
ABSTRACT
This paper explores the 3.0T magnetic resonance (MRI) image for measuring the characteristics of endometrial cancer, and evaluates the value of MRI plain scan plus enhanced combined diffusion-weighted imaging (DWI) in preoperative staging information sensing of endometrial cancer. The paper retrospectively analyzed the clinical data of 202 patients with endometrial cancer who were admitted to the gynecology department of our hospital from January 2014 to August 2018. All patients in this group underwent MRI. The study found that 202 patients with endometrial cancer were confirmed by surgical pathology: 131 patients in stage IA, 28 patients in stage IB, 15 patients in stage II, 3 patients in stage IIIA, 16 patients in stage IIIB, 4 patients in stage IIIC1, 1 patient in stage IIIC2, and IVA stage There were 1 case and 3 cases in IVB stage. Therefore, it can be concluded that, in endometrial cancer, the coincidence rate between 3.0TMRI preoperative staging and postoperative pathological staging is high, and it can be used as a routine examination before endometrial cancer patients, thus providing objective basis for clinical decision-making.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.